A fabulous, complimentary life science networking reception is coming up during Advances in Single Cell & Spatial Biology on 9/14. CG Life is co-hosting. It should make for an excellent evening of drinks, bites, and science!

Roche buys U.S. rights to Roivant bowel disease drug in $7.1 billion deal

New Cancer Therapy Target Stops Tumor Cells From Sharing Resources

Oncolytic Virus Improves Survival in Glioblastoma Trial via @GENbio

Seed-stage Bay Area biotechs kick off return of BIO Investor Forum - San Francisco Business Times via @SFBusinessTimes

Carl Icahn sues Illumina board members over Grail acquisition -

Flipped coins found not to be as fair as thought via @physorg_com

Aldeyra braces for potential dry eye disease rejection after FDA says more data are necessary -

These Japanese life science firms came to San Diego to study startups

Better Therapeutics begins rolling out digital app for Type 2 diabetes

Pfizer Expands in Immunology With FDA Approval of New Ulcerative Colitis Drug

Thermo Fisher Scientific to buy Olink in $3.1 billion deal

Sanofi adds another AI alliance, this time for biologics with Baidu CEO’s startup -

RT @gwendolynawu: A decade later, biotech’s CRISPR revolution is still going strong. I traced the history of gene editing startups and what…

Chemogenetics Can Dampen Pain Responses in Lab Tests via @clinicalomics

Cell Therapy for Drug-Resistant Epilepsy a Preclinical Success via @GENbio

Twist Bioscience, Bayer Enter Antibody Discovery Deal Valued at up to $188 Million via @clinicalomics

RT @cglifeagency: Researchers are using CRISPR for more complex diseases such as Alzheimer's. Studies done at @UCSanDiego, @DukeU, and more…

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone $ETON via $ETON

BridgeBio and Resilience Form Gene Therapy Partnership via @GENbio

Gilead stops another CD47 study, this time in acute myeloid leukemia -